Jump to content

Covaxin - asalu adhi vaccine eh na ?


coffee

Recommended Posts

3 minutes ago, Piracy Raja said:

testing eppudo appesaru kada

Currently in India testing here is in full swing all private labs test for 500 rs for 1200rs they come to your house and collect swab. Govt testing centers are numerous and free. Results come in 8hrs way way better than US.

Link to comment
Share on other sites

3 minutes ago, LadiesTailor said:

Em vaccine ee ento... already india lo herd immunity vachesindi and people are living normal Life... vaccine pedda use vundadu ani naa yokka idhi 

Herd immunity ante emi ledhu..chacche valu chastharu light ani tiskuntunnaru.

 

Basically in india they don't care elederly ani clear ga message

Link to comment
Share on other sites

endi vayya meeru. phase 3 testing ayyindi. they did not release the data ante. main governing body says that they would not have approved it had it not been successful. 

stop saying that phase 3 tests did not happen

Link to comment
Share on other sites

5 minutes ago, coffee said:

Herd immunity ante emi ledhu..chacche valu chastharu light ani tiskuntunnaru.

 

Basically in india they don't care elederly ani clear ga message

Yeah correcte 

Link to comment
Share on other sites

20 minutes ago, Sachin200 said:

Covaxin inactive virus and it should be safe Ani antunaru . People will have no choice and government will choose either Covaxin or covishield 

ErtLpBoVEAMgf8A?format=jpg&name=medium

 

Both Vaccines are inactive virus -- The regular vaccine model that we know off... Brahmi-2_1.gif?1337103173

Link to comment
Share on other sites

7 minutes ago, rajahmundry_bullodu said:

endi vayya meeru. phase 3 testing ayyindi. they did not release the data ante. main governing body says that they would not have approved it had it not been successful. 

stop saying that phase 3 tests did not happen

Phase 3 status 

What about efficacy data?

There is no efficacy data at the moment, said Ella, as the phase-3 trial is ongoing and is yet to hit the 146-Covid infection mark, which triggers an interim analysis to measure the efficacy of the vaccine.

He said that in the next 2-3 days, the company intends to complete dosing of Covaxin in 26,000 subjects with the first dose. Bharat Biotech expects to complete the second dose by February-March. He said that in the past, vaccines were approved based on immunogenicity data if they hit a certain threshold. Ella expressed confidence that Covaxin would meet or exceed the 50 percent efficacy benchmark.

  • Upvote 1
Link to comment
Share on other sites

2 minutes ago, Anta Assamey said:

Both Vaccines are inactive virus -- The regular vaccine model that we know off... Brahmi-2_1.gif?1337103173

Eppudu India astrazeneca kav prefer chestaru ( with known efficacy ) . But govt decide chestadi which one to take and people can opt out 

Link to comment
Share on other sites

59 minutes ago, coffee said:

Bharat Biotech to pay compensation if Covaxin causes side effects

The vaccine maker said in phase 1 and phase 2 clinical trials, Covaxin has demonstrated the ability to produce antidotes against COVID- 19

Posted: Jan 16, 2021 03:28 PM   Updated: 1 min ago

Beautiful Image

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) in New Delhi on Saturday. REUTERS

Hyderabad, January 16

Bharat Biotech, which has received a government purchase order for supply of 55 lakh doses of Covaxin, a COVID-19 vaccine, said the company would pay compensation to recipients in case of any serious adverse effects experienced after receiving the antidote.

In the consent form to be signed by the vaccine recipients, Bharat Biotech said: “In case of any adverse events or serious adverse events, you will be provided medically recognised standard of care in the government designated and authorised centres/hospitals.”

“The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine,” the consent form said.

So they only not sure about quality 

Link to comment
Share on other sites

3 minutes ago, Sachin200 said:

Eppudu India astrazeneca kav prefer chestaru ( with known efficacy ) . But govt decide chestadi which one to take and people can opt out 

Yes I agree people should be given option of the vaccine when they are paying for it or even if it is free.

But the only logistical problem is government will not which vaccine to produce / buy more compared to one another...Brahmi-2_1.gif?1337103173

Link to comment
Share on other sites

1 minute ago, Anta Assamey said:

Yes I agree people should be given option of the vaccine when they are paying for it or even if it is free.

But the only logistical problem is government will not which vaccine to produce / buy more compared to one another...Brahmi-2_1.gif?1337103173

Serum institute vs baharat biotech ..Evi.entha produce chestaro 

Celebrities /polticians edhi teesukuntaro adhi relatively safe anatu 

Link to comment
Share on other sites

3 minutes ago, Sachin200 said:

Serum institute vs baharat biotech ..Evi.entha produce chestaro 

Celebrities /polticians edhi teesukuntaro adhi relatively safe anatu 

Obviously will trust COVISHEILD.... which has more data...Brahmi-2_1.gif?1337103173

  • Upvote 1
Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...